Next Generation Vaccines Conference, October 21-22 2010,Vienna, Austria
Cellular Immunotherapy for Men with Advanced Prostate Cancer
DNA Vaccines 2010, March 2 - 4, 2010, New Orleans, LA
A New Trivalent Seasonal Influenza Candidate Vaccine Shows 78 Percent Rate of Prevention Against Matching Influenza Strains
Leukemia Vaccine Shows Promise
Cell-based Viral Vaccines: FDA Issues Final Guidance
Anthrax Vaccine Contract for $78.4 Awarded by HHS
Pneumococcal Disease Vaccine Approved by FDA
Gates Foundation Will Commit $10 Billion for Vaccine Development
Government Commission Calls for Faster Vaccine Production Technologies
Contact Us